Good to bring that publication back to remind all....and I would say Forty Seven at Stanford is interested in PS Targeting ...especially since Jason Stafford works with PS Targeting and now there
Another blind collaboration we don't see yet it seems
Sunstar, on clinicaltrials.gov it says that trial was terminated 3/2/16. Do you know if it was completed or was it shut down as a result of the Sunrise termination?